Breaking the log-jam in treatment development for cognition in schizophrenia: NIMH perspective

Psychopharmacology (Berl). 2003 Sep;169(3-4):365-6. doi: 10.1007/s00213-003-1564-1. Epub 2003 Sep 2.

Authors

Wayne S Fenton¹, Ellen L Stover, Thomas R Insel

Affiliation

¹ National Institute of Mental Health, National Institute of Health, US Department of Health and Human Services, Room 6216, 6001 Executive Boulevard, MSC 9621, Bethesda, MD 20892-9621, USA. wfenton@mail.nih.gov

PMID: 12955292
DOI: 10.1007/s00213-003-1564-1

No abstract available

MeSH terms

Animals
Cognition Disorders / drug therapy*
Cognition Disorders / etiology
Humans
National Institute of Mental Health (U.S.) / trends*
Psychopharmacology
Schizophrenia / complications*
Schizophrenia / drug therapy
United States